Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$5.06 - $10.78 $539,411 - $1.15 Million
-106,603 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$5.64 - $23.33 $78,982 - $326,713
-14,004 Reduced 11.61%
106,603 $645,000
Q4 2020

Feb 02, 2021

BUY
$3.5 - $7.98 $41,314 - $94,195
11,804 Added 10.85%
120,607 $689,000
Q3 2020

Nov 05, 2020

BUY
$4.78 - $16.97 $520,078 - $1.85 Million
108,803 New
108,803 $724,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.